Gemcitabine/Cisplatin±Sorafenib for the First-Line Treatment of Chemonaive Chinese Patients with Advanced, Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Subgroup Analysis of the Phase III NExUS Trial

被引：0
|
作者：
Liao, Meilin [1 ]
Zhang, Li [2 ]
Sun, Yan [3 ]
Yu, Shiying [3 ]
Pan, Hongming [4 ]
Zhou, Caicun
Jiang, Anastasia
Montegriffo, Elaine
Ong, Teng Jin
Gatzemeier, Ulrich [5 ]
机构：
[1] Shanghai Chest Hosp, Clin Med Ctr Lung Tumor, Dept Pulm Oncol, Shanghai, Peoples R China
[2] Sun Yat Sen Univ, Dept Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Tongji Hosp, Dept Oncol, Shanghai, Peoples R China
[4] Sir Run Run Shaw Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [21] A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    McMillan, Alex
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhmani
    Zhou, Lisa
    San Pedro-Salcedo, Melanie
    Colevas, A. Dimitrios
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (11) : 1821 - 1825
  • [22] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [23] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
  • [24] A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
    Blackhall, Fiona H.
    O'Brien, Mary
    Schmid, Peter
    Nicolson, Marianne
    Taylor, Paul
    Milenkova, Tsveta
    Kennedy, Sarah J.
    Thatcher, Nick
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1285 - 1288
  • [25] Efficacy of pemetrexed-cisplatin (PC) in East Asian patients (pts): Subgroup analysis of a phase III study comparing PC versus gemcitabine-cisplatin (GC) in first-line treatment of advanced non-small cell lung cancer (NSCLC)
    Orlando, M.
    Lee, J. S.
    Yang, C.
    Simms, L.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [27] Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL
    Reck, Martin
    von Pawel, Joachim
    Zatloukal, Petr
    Ramlau, Rodryg
    Gorbounova, Vera
    Hirsh, Vera
    Leighl, Natasha
    Mezger, Joerg
    Archer, Venice
    Moore, Nicola
    Manegold, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1227 - 1234
  • [28] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [29] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Jin, S. S.
    Min, Y.
    Kim, H.
    Ahn, J.
    Jegal, Y.
    Seo, K.
    Park, C.
    Shin, J.
    Cha, H.
    Kwon, W.
    Park, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Shin, S. J.
    Min, Y. J.
    Baek, J. H.
    Kim, H.
    Ann, J. J.
    Jegal, Y. J.
    Park, C. Y.
    Cha, H. J.
    Kwon, W. J.
    Park, J. H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 381 - 381
12345